Stay updated on Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.

Latest updates to the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page
- Check2 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, signaling a small internal version update to the page. There are no changes to the study data or displayed content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision was updated to v3.5.2, replacing the previous v3.5.0 revision.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now displays revision: v3.4.3 in place of the previous v3.4.2.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.4.2 was applied to the site, and the previous notice about government funding operating status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check88 days agoChange DetectedAdded a site-wide funding-status notice and updated the page revision to v3.4.1; no study content or data were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.